Early and persisting response to vismodegib in a patient with bone metastasizing medulloblastoma

Authors

  • Thomas Asklund Institution of Radiation Sciences, Umeå University Hospital, Umeå, Sweden
  • Roger Henriksson Institution of Radiation Sciences, Umeå University Hospital, Umeå, Sweden
  • Jan Axelsson Institution of Radiation Sciences, Umeå University Hospital, Umeå, Sweden
  • Åsa Bergström Center for Biosciences, Department of Bioscience and Nutrition, NOVUM, Huddinge, Karolinska Institute, Sweden
  • Maria Kasper Center for Biosciences, Department of Bioscience and Nutrition, NOVUM, Huddinge, Karolinska Institute, Sweden
  • Margareta Ögren Institution of Radiation Sciences, Umeå University Hospital, Umeå, Sweden
  • Rune Toftgård Center for Biosciences, Department of Bioscience and Nutrition, NOVUM, Huddinge, Karolinska Institute, Sweden
  • Katrine Åhlström Riklund Institution of Radiation Sciences, Umeå University Hospital, Umeå, Sweden

DOI:

https://doi.org/10.3109/0284186X.2012.724537

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Additional Files

Published

2013-05-01

How to Cite

Asklund, T., Henriksson, R., Axelsson, J., Bergström, Åsa, Kasper, M., Ögren, M., … Åhlström Riklund, K. (2013). Early and persisting response to vismodegib in a patient with bone metastasizing medulloblastoma. Acta Oncologica, 52(4), 862–865. https://doi.org/10.3109/0284186X.2012.724537

Issue

Vol. 52 No. 4 (2013): Acta Oncologica

Section

Articles